Plasma renin and aldosterone after renal transplantation  by Beckerhoff, Rainer et al.
Kidney International, Vol. 5 (1974), p. 39—46
Plasma renin and aldosterone after renal transplantation
RAINER BECKERHOFF, GEORG UHLSCHMID, WILHELM VETTER, HELMUT ARMBRUSTER
and WALTER SIEGENTHALER
Departments of Medicine and Surgery A, Kantonsspital, University of Zurich, Switzerland
Plasma renin and plasma aldosterone after renal transplanta-
tion. Plasma renin activity (PRA) and plasma aldosterone (PA)
were measured in 19 renal allograft recipients during the first
month after transplantation. PRA and PA were elevated in most
patients during the first days. The values were significantly
higher in patients with late onset of graft function than in patients
whose kidneys worked well from the transplantation on. After
three to four weeks most PRA and all PA values were within the
normal ranges. It is suggested that the ischemia during trans-
plantation is the cause of renin elevation. Elevation of PA is
most likely the consequence of increased angiotensin II generated
by high PRA, indicating that the renin-angiotensin-aidosterone
relationship is unaltered in many patients after renal transplan-
tation. A dissociation between PRA and PA was observed in
several cases. Similar observations have been made in patients
with terminal renal failure. The phenomenon cannot be fully
explained. Significant increases in PRA and PA were observed
after two hours of ambulation demonstrating that the postural
renin response is unaltered in transplanted and, thus, denervated
kidneys. No consistent relationship between acute graft re-
jection and PRA could be demonstrated. There was no significant
correlation between PRA and blood pressure after trans-
plantation.
Rénine et aldostérone plasmatiques après transplantation rénale.
L'activité refine (PRA) et l'aldostérone plasmatiques (PA) ont
été mesurées chez 19 receveurs de transplant renal pendant Ic
premier mois aprés la transplantation. PRA Ct PA sont élevés
chez Ia plupart des malades durant les premiers jours. Les
valeurs sont significativement plus élevées chez les malades dont
Ia reprise fonctionnelle du transplant est retardée que chez ceux
dont le rein fonctionne bien d'emblée. Apres trois ou quatre
semaines la plupart des valeurs de PRA et PA sont dans l'éventail
des valeurs normales. II est suggéré que l'ischémie au cours de Ia
transplantation est la cause de l'augmentation de PRA. L'aug-
mentation de PA est trés probablement la consequence d'une
augmentation de l'angiotensine II génerée pa l'élévation de PRA.
Cela indique que la relation rénine angiotensine aldostérone
n'est pas modifiée chez beaucoup de malades après transplan-
tation. Une dissociation entre PRA et PA a été observée dans
quelques cas. Des observations semblables ont été faites chez
des malades atteints d'insuffisance rénale terminale. Cette
dissociation ne peut Ctre clairement expliquee. Des augmenta-
tions significatives de PRA et PA ont été observées aprés deux
heures de déambulation, cc qui démontre que Ia réponse de Ia
refine a Ia posture n'est pas modifiée dans les reins transplantés
Ct done dénervés. Aucune relation entre le rejet aigu et PRA n'a
Pu être démontrée. II n'y a pas de correlation significative entre
PRA et pression artérielle aprés transplantation.
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The transplanted kidney can produce renin [1—5].
Elevated plasma renin activity has been observed
following transplantation in several cases and it has
been explained by allograft rejection [2—7], ischemic
damage of the transplant and tubular necrosis [3—5],
occlusive vascular lesions of the graft artery or its
branches and infarction of the graft [4] or irradiation
of the graft [5].
In this study, the early posttransplant course of 19
patients with kidney allografts has been investigated.
Plasma renin activity and plasma aldosterone con-
centration have been measured serially in each patient
during the first month after transplantation. An at-
tempt was made to elucidate the factors influencing
plasma renin activity in kidney allograft recipients.
t.Jnder normal conditions the renin-angiotensin system
plays an important role in the control of aldosterone
secretion. Therefore, it was of interest to study the
relationship between plasma renin and plasma aldo-
sterone in patients who had been anephric or living
with an extremely reduced renal function and who
subsequently received kidney transplants.
Methods
Clinical studies. Nineteen patients who received renal
transplants at Kantonsspital Zurich were included in
this study. The patients consisted of ten female and
nine male subjects. The mean age was 44 years with a
range from 18 to 59 years. The underlying diseases
leading to chronic renal failure and maintenance
hemodialysis were chronic glomerulonephritis in eight
cases, polycystic kidneys in four cases, chronic pyelone-
phritis in three cases, interstitial nephritis in two cases
and oxalosis and Alport's syndrome in one case each.
The patients were regularly dialyzed in seven different
Swiss hospitals prior to transplantation. Ten patients
received antihypertensive medication during the time
preceding transplantation. Six patients received
methyldopa alone in doses between 500 and 1500 mg
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daily. The other four patients received other anti-
hypertensives (reserpine, clonidine, hydralazine) either
alone (two patients) or in combination with methyl-
dopa (two patients). Seven patients had undergone
bilateral nephrectomy one week to nine months before
transplantation. Nephrectomy was performed at the
time of transplantation in the other 12 patients. The
patients received cadaver kidneys from unrelated
donors. Immunosuppressive therapy, azathioprine
and prednisone, was routinely given to each patient.
Azathioprine, 300 mg, was given for the first three
days. The daily dose was reduced from the fourth day
on and was between 50 and 150 mg at the end of the
first month. The usual dose of prednisone was 50 mg
daily. Ten ml of anti-human lymphocyte globulin
(AFILG, Behring-Werke Marburg, Germany) con-
taining 50 mg of globulin per ml was given daily to all
patients with a negative intracutaneous AHLG test.
The AHLG was diluted in 100 ml of physiologic saline
solution and infused over a period of 30 mm. The dose
of prednisone was increased transiently when clinical
signs of rejection were present. The transplanted organ
had to he removed in one patient at the ninth day due
to acute rejection. The kidneys of the other 18 patients
functioned well at the end of the first month.
The patients were divided into two groups according
to how the graft functioned during the first days
following transplantation. Group A consisted of seven
patients who required repeated hemodialysis during
the early postoperative period because of late onset of
sufficient graft function. Urine output was less than
500 ml in each of these patients for at least three days.
Group B consisted of 12 patients whose transplanted
kidneys functioned well from transplantation on.
Urine output was greater than 4000 mI/day for one to
four days in six of the 12 patients.
The patients were fed a regular hospital diet when
they were able to eat normally and when no hemodia-
lysis was required. During the immediate post-
operative period when intravenous therapy was neces-
sary, sodium, potassium and water intake were
measured. Frequent determinations of blood pressure
and serum sodium and potassium concentrations were
performed. From the sixth postoperative day on, when
the patients were allowed to get up, body weight was
measured daily.
Venous blood for plasma renin activity and plasma
aldosterone concentration was drawn according to a
fixed schedule. Whenever possible, one sample was
drawn before transplantation. The next specimens
were obtained at the mornings of day 1 and day 2,
once between days 3 and 5 and once between days 7
and 9 after transplantation. Two additional studies
were done during the third and fourth postoperative
weeks, When the patients were undergoing hemo-
dialysis (group A) blood was drawn with few excep-
tions at least 24 hours after dialysis. The effect of
posture on plasma renin activity and plasma aldo-
sterone was studied twice in seven patients and once
in two patients. These studies were carried out during
the third and the fourth postoperative weeks. Blood
was drawn at 8 AM after overnight bedrest and at 10 AM
after the patients had been in the upright position for
two hours. Sodium intake was not controlled during
the time when these studies were performed. The paired
t test was used to compare values before and after
standing.
Plasma cortisol concentration was measured during
the first postoperative week in 11 patients. Cortisol
was measured in the same specimens as aldosterone
and plasma renin activity.
Analytical methods. Plasma renin activity was
measured using a radioimmunoassay for angiotensin I
[8] and expressed as ng of angiotensin I generated per
ml of plasma after three hours of incubation (ng/ml x
3 hr). The normal range in our laboratory for normals
on a 120 to 150 mEq sodium diet, fasting and after
overnight recumbency, is 0.3 to 3.0 ng/ml x 3 hr. The
interassay variability of the method in our laboratory
is 8.9% (N= 14).
Plasma aldosterone concentration was measured by
radioimmunoassay. The method used in our labora-
tory is detailed elsewhere [9]. Briefly, plasma is ex-
tracted with methylene chloride. The methylene
chloride extract is dried and the residue redissolved in
buffer. The aldosterone concentration of the extract
solution can be measured by radioimmunoassay
without further purification procedures because of the
high specificity of the antiserum [10]. Cross-reaction
with other steroids is as follows: cortisol, 0.00l%;
corticosterone, 0.05; I 1-deoxycortisol, 0.001%; and
cortisone, 0.002%. The interassay variability of the
method is I 4% (N= 20). The normal range for normal
subjects on a 120 to 150 mEq sodium diet, fasting after
overnight recumbency, is 25 to 100 pg/mI.
Plasma cortisol concentration was measured by
protein binding [11] using dextran-coated charcoal
for separation of bound from free hormone. The nor-
mal range for normal subjects, fasting after overnight
recumbency, is 5 to 25 ig/100 ml.
Results
Plasma renin activity. Plasma renin activity was
measured in 16 patients before transplantation (Table
1). No renin activity was detectable in the plasma of
four anephric patients (two men, two women). Renin
activity was within the low normal range in two other
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Table 1. Plasma renin activity (PRA) and plasma aldosterone
(PA) concentration in 16 patients before renal transpiantationa
Patient
No.
Sex PRA
ng/ml x 3 hr
PA
pg/mi
Antihypertensive
drugs
I F <0.16 94 —
2 F <0.16 48 +
3 M <0.16 20 —
4 M <0.16 28 —
5 F 0.5 154 --
6 F 0.4 40 +
7 M 6.0 82 +
8 M 2.7 288 +
9 M 10.6 342 —
10 F 8.2 252 +
11 F 2.8 114 —
12 F 20.0 1550 +
13 M 7.3 124 +
14 M 40.0 1180 —
15 F 3.4 126 —
16 M 0.4 40 +
The first six patients were anephric. The use of antihypertensive
therapy is indicated in the right column.
anephric women. In ten patients with kidneys still in
situ, plasma renin activity ranged from 0.4 to 40 ng/ml
x 3 hr. Six of the ten patients received antihyperten-
sive therapy. Their renin values were not significantly
different from the renin activities of the four patients
who were without antihypertensive therapy. There was
no significant correlation between plasma renin activ-
ities before and after transplantation.
Plasma renin activities measured in recumbent
patients during the first month after transplantation
are shown in Fig. 1. Most values during the first and
second postoperative day were above the range found
in normal recumbent subjects. Mean plasma renin
activity was 11.5 ng/ml x 3 hr on the first day. Al-
though several values were within the normal range
during the first and second postoperative day, plasma
renin activity was consistently normal in only two of
the 19 patients. In three patients plasma renin activity
was normal at the first day but rose later to abnormally
high values while in one patient a high renin activity
was observed only at the first postoperative day.
When all values obtained between the first and fifth day
were compared, the plasma renin activity of group A
patients was significantly higher than of group B
patients (Table 2).
Mean plasma renin activity decreased from the
first postoperative day on (Fig. 1). Most values were
within the normal range at three to four weeks after
transplantation. At this time, there was no significant
difference in values between group A and group B
(Table 2). A few elevated values were observed during
the third postoperative week. They could not be related
Fig. 1. Plasma renin activity and plasma aldosterone concentration
in 19 patients during the first month after renal transplantation.
The mean values are connected by lines. The triangles indicate
observations during episodes of acute graft rejection. The normal
ranges are shown as shaded areas.
to any abnormality in blood pressure, kidney function,
diet or medication.
Plasma renin activity was measured during the four
rejection episodes which were observed during the
time of observation. Clinical signs of rejection were
first noted during the fifth to eighth postoperative day.
Nephrectomy had to be performed in one patient on
day 9. Clinical signs of rejection were confirmed by
histologic examination of needle biopsy specimens in
the remaining cases. Plasma renin activity was ele-
vated during the period of rejection in two patients
and was normal in two other cases (Fig. 1, Table 3).
Plasma aldosterone. Plasma aldosterone ranged
from 20 to 1550 pg/ml before transplantation (Table 1).
Anephric patients had lower aldosterone concentra-
tions than nonnephrectomized patients. The difference
was not significant, however, because of the wide range
of plasma aldosterone concentrations. There was a
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PRA
ng/mix3hr
Group A Group B Group
PA
pg/miA Group B
Days I to 5
N 17 33 15 32
Mean 10,9 6.1 337 105
SEM 1.9 1.3 117 29
P <0.05 <0.02
Days 7 to 30
N 16 31 17 32
Mean 4.0 4.1 55 45
SEM 1.8 0.8 15 9
P >0.5 >0.5
N=number 01' observations. Student's
calculation of the P values.
t test was used for
Patient
No.
Postoperative
day
PRA
ng/mlx 3 hr
PA
pg/mi
1 8 6.6 42
13 7 8.2 46
5 8 2.7 125
16 7 2.2 20
significant positive correlation between plasma renin
activity and plasma aldosterone in the ten patients
with their kidneys in situ in whom preoperative
measurements were performed (N= 10, ,'=0.816,
P<0.0l).
Plasma aldosterone concentration was elevated
above the upper limit of normal in 17 of 35 samples
during the first and second day after transplantation
(Fig. 1). From the third postoperative day on, few
samples were above the range found in recumbent
healthy subjects. No elevated values were observed
between day 20 and day 30. Plasma aldosterone con-
centration was significantly higher in patients of group
A than in patients of group B during the days fol-
lowing transplantation (Table 2). Later, there was no
significant difference between group A and group B
values. There was a significant positive correlation
between individual plasma aldosterone and plasma
renin levels during the first to fifth day (N= 47, r =0.54,
P<0.OOl) (Fig. 2). Mean plasma aldosterone con-
centrations of each of the six time periods were
significantly correlated to mean plasma renin activi-
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Fig. 2. Correlation between plasma renin activity and plasma
aidosterone concentration during the first to fifth day after renai
transpiantation in patients with late Onset of graft function (group
A, 0) and in patients with early onset of graft function (group B,
•). n=47, r=0.54, P<0.001, y=19.7x +24.7.
ties (N=6, r=0.98, P<0.001). A multiple regression
equation showed a significant correlation of plasma
aldosterone with plasma renin activity and potassium
concentration combined (N=47, r=0.57, P<0.00l).
Plasma aldosterone concentration was normal during
three of the four rejection episodes which were observed
and was slightly elevated (125 pg/mi) in one case
(Fig. 1, Table 3).
The effect of posture on plasma renin activity and
plasma aldosterone con centration. Mean plasma renin
activity rose from 2.4 0.7 (mean SEM) to 7.8 2.6
ng/ml x 3 hr (P <0.05). Mean plasma aldosterone
concentration rose from 36 6 to 138 28 pg/mi
(P <0.005) (Fig. 3).
Plasma cortisol. Plasma cortisol concentration was
normal during the first postoperative week in ten of
11 patients in whom it was measured (Table 4). One
individual (patient 12) showed elevated plasma cortisol
concentrations.
Serum sodium and serum potassium concentrations.
The concentration of serum sodium was relatively low
and that of serum potassium relatively high in many
patients after transplantation. At day I, serum sodium
Table 2. Plasma renin activity (PRA) and plasma aldosterone
concentration (PA) during the early (days I to 5) and late course
(days 7 to 30) after renal transplantation in patients of group A
(transiently anuric after transplantation) and in patients of group
B (normal function of the graft)
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Table 3. Plasma renin activity (PRA) and plasma aldosterone
concentration (PA) during acute rejection
20
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concentration was 131 1.2 mEq/liter and serum
potassium was 4.7 1.2 mEq/liter. Serum electrolytes
normalized within a period of days to weeks. After
four weeks, serum sodium concentration was 139 1.2
mEq/liter and that of serum potassium, 4.2±0.1
mEq/liter. There was no significant correlation be-
tween serum sodium or serum potassium and plasma
renin activity or plasma aldostrone during the time of
observation.
Blood pressure. The average arterial blood pressure
of all 19 patients during the months preceding trans-
plantation was 160/97 mm Hg. In almost all patients,
blood pressure increased transiently after transplanta-
tion, reaching a maximum in individual patients be-
tween days 3 and 7. The average blood pressure in-
creased from 160/95 mm Hg (day I) to 178/101 mm Hg
(day 4). Antihypertensive medication was given to ten
patients at this time (three patients of group A and
seven patients of group B). Methyldopa was given in
doses between 500 and 1500 mg daily. Reserpine
therapy, 0.2 mg daily, was given in addition to two
Table 4. Plasma cortisol concentration measured in 11 patients
during the days following renal transplantation after overnight
bedrest
Patient Plasma cortisol, p.g/100 nil
Days post renal transplantation
1 2 3to5
1 8.7 3.2 11.5
2 5.3 4.7 4,9
7 5.! — 20.5
17 11.5 5.5 13.0
8 8.0 — —
9 13.0 9.3
10 8.8 7.7 5.4
5 20.4 5.5 7.0
11 14.5 12.0 10.0
12 44.5 30.7 35.0
18 11.0 7.0 7.2
patients. The average blood pressure decreased from
the fifth postoperative day on and was 137/86 mm Hg
at the end of the first month. Two patients still received
treatment with antihypertensives. There was no sig-
nificant correlation between plasma renin activity and
systolic, diastolic or mean arterial pressure.
Body weight. Body weight decreased in all but two
patients from the time when it was regularly checked
(usually from day 6). Mean body weight decreased
from 61.3±2.1 to 57.0±2.1 kg during the fourth
week.
Discussion
The present data show that a marked increase in
plasma renin activity occurs in most patients after
renal allotransplantation. Renin activity reaches a
maximum during the first and second postoperative
days. Plasma renin activity is significantly higher in
patients in whom transplantation is followed by several
days of anuria or oliguria than in patients with good
function of the graft. A gradual decline from the first
day on is seen and there are only a few elevated values
at three to four weeks.
Elevated renin activities have also been reported by
other authors in renal transplant recipients [2—7].
None of the investigators has, however, reported such
a relative uniform behavior of plasma renin activity
within a group of patients, probably because frequent
serial determinations as in this study have not been
done.
The factors regulating renin secretion in normal men
cannot alone be responsible for the elevation of plasma
renin activity after transplantation. Blood pressure
did not decrease during the days following transplan-
tation. Intake of fluids and electrolytes was carefully
adjusted to losses. Central venous pressure was meas-
ured in all patients. A decrease in body weight was
Fig. 3. Plasma renin activity and plasma aldosterone concentra-
tion in renal transplant recipients during the first month after
transplantation after overnight recumbency (—o) and after two
hours of ambulation (9). The mean values are connected by
thick lines. The t test for paired observations was used for cal-
culation of the P values.
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observed from the moment when it was regularly
checked. These observations indicate that the patients
were not volume-depleted and that, therefore, volume
depletion was probably not the cause of renin ele-
vation. Other investigators could also show that
plasma renin activity after renal transplantation is not
correlated to changes in body weight [4] or plasma
volume [3].
Serum sodium concentration was relatively low
during the days after transplantation. There was,
however, no significant correlation between serum
sodium and plasma renin activity. This indicates that
changes of serum sodium concentration were prob-
ably not a major cause for the changes of plasma
renin activity during the postoperative period. It
cannot be excluded, however, that in certain individual
cases a low serum sodium concentration had an ad-
ditional stimulating effect for an increased secretion of
renin.
Elevated plasma renin activity has frequently been
observed during episodes of graft rejection [2—5, 12].
In this study, four rejection episodes were observed
during the end of the first postoperative week. Ele-
vated plasma renin activity was present in only two of
the four patients (Table 3). Four episodes of acute
graft rejection is too small a number to draw conclu-
sions from our data on the frequency of elevation of
plasma renin activity during renal homograft rejection
in general. It can be stated, however, that in this series
graft rejection was not the cause of elevated plasma
renin activity during the immediate postoperative
period. Graft rejection may be a major cause of renin
elevation, particularly during the later posttransplant
course.
Diuretic therapy can be excluded as a cause of renin
elevation in this series because diuretics were not given
during the days after transplantation. Among other
medications which may influence the renin-angiotensin
system, antihypertensives are of special interest. Many
patients received methyldopa during the period of
observation. Methyldopa reduces the plasma renin
activity [13] and can, therefore, be excluded as a cause
of elevation of plasma renin activity after transplan-
tation. Moreover, no antihypertensives were given
during the first three postoperative days when the
highest plasma renin values were observed.
During the days after transplantation the trans-
planted kidney in many ways resembles the kidney
during acute renal failure. A transient anuria is fre-
quently observed, followed by a recovery phase during
which a plyuric period can be seen. Tubular necrosis
may be seen and elevation of plasma renin activity is
present in many cases of acute renal failure [14—17]
and after kidney transplantation (Fig. 1).
There are several conditions which may cause
damage to a kidney during transplantation and induce
postoperative anuria or impairment of the function
of the graft. These include agonal hypotension of the
donor, warm ischemia before perfusion and during
reimplantation, and cold storage for several hours.
Transient ischemia of the kidney is followed by a
striking change in renal circulation [18—20]. The renal
blood flow is significantly reduced. Swelling of capillary
endothelial cells may partly be responsible for the "no
reflow" after ischemia [21, 22]. Reduced renal blood
flow as a consequence of ischemia is a stimulus for
renin release and may well be one major cause for the
observed increase in plasma renin activity after kidney
transplantation.
On the other hand, an intrarenal activation of the
renin-angiotensin mechanism leading to vasocon-
striction may itself be a major cause, rather than a
consequence, of decreased renal blood flow and re-
duced glomerular filtration rate after ischemia [23].
The importance of each of these mechanisms is still
uncertain. The observation that plasma renin activity
was elevated to a greater extent in anuric patients
(group A) may favor the hypothesis that renin is
actively involved in the pathogenesis of acute anuria
[14, 23]. On the other hand, plasma renin activity was
also elevated in most normouric and polyuric patients
(group B). This is an indication that elevation of plasma
renin is a relatively nonspecific sign for the alteration
in renal circulation which is induced by ischemia during
transplantation.
Plasma aldosterone concentration was frequently
elevated during the days following transplantation.
Increased plasma angiotensin II concentration, gen-
erated by elevated plasma renin activity, is most likely
the major cause for this hyperaldosteronism which has
not been reported previously, Angiotensin 11, a potent
stimulus for aldosterone secretion, had been absent
in several patients who had been anephric for various
intervals prior to transplantation. The fact that high
plasma renin activity was accompanied by high plasma
aldosterone indicates that the adrenal glands of these
patients still responded to the stimulus of angiotensin
in an essentially normal manner.
Low serum sodium and relatively high serum
potassium concentrations after transplantation may
have an additional stimulatory effect on aldosterone
secretion. However, the changes in these electrolytes
were too small to explain the great changes in plasma
aldosterone. We were, as other investigators [24],
unable to demonstrate a significant correlation be-
tween plasma aldosterone and serum potassium con-
centrations in renal transplant recipients. Cortico-
tropin, another factor which may stimulate aldosterone
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may increase during such stress situations as opera-
tions. Plasma cortisol was measured as an indirect
index for corticotropin activity. Plasma cortisol was
within the normal range in ten of 11 patients in whom
it was measured indicating that there was probably no
increased corticotropin activity during the times when
blood for aldosterone was collected. Medication with
synthetic steroid hormones may also have reduced
corticotropin release.
Although there was a significant positive correlation
between plasma renin activity and plasma aldosterone
during the days following transplantation, there were
several patients with normal plasma aldosterone but
elevated plasma renin values. During two rejection
episodes, elevated plasma renin activity was also
accompanied by normal plasma aldosterone con-
centration. It is unlikely that different serum con-
centrations of sodium or potassium were a major cause
of the dissociation between aldosterone and plasma
renin activity. There was no significant correlation
between each of the electrolytes and plasma aldo-
sterone. The correlation coefficient between plasma
aldosterone and plasma renin activity was almost
unchanged when a multiple regression analysis was
performed which included serum potassium
concentration.
High plasma renin activities which are accompanied
by normal plasma aldosterone concentrations have
also been observed by Weidmann, Maxwell and Lupu
[25] and by our group [26] in patients with terminal
renal failure. It can be suggested that the sensitivity
of the adrenal gland for increased angiotensin is
lowered in some patients with terminal renal failure
and in some patients after renal transplantation. The
reason for the altered sensitivity is still unknown.
The effect of orthostasis on plasma renin activity
and on plasma aldosterone in renal transplant re-
cipients has been investigated by several authors [12,
24, 27, 28]. The results of this study confirm most of
their observations. An increase in plasma renin activity
and also in plasma aldosterone concentration is
observed in almost all patients with transplanted and,
thus, denervated kidneys. Innervation of the kidney
is not necessary for the postural renin stimulation. The
magnitude of renin stimulation after orthostasis varies
considerably between individual patients (Fig. 3). Very
low and very high values are observed. This is in
contrast to the observation that all patients have a
subnormal increase in plasma renin after transplan-
tation when they are stimulated by orthostasis [12].
One explanation for the variable renin stimulation
observed in this study may be that the renal blood flow
was reduced during orthostasis to different degrees in
individual patients depending on the anatomical posi-
tion of the graft, thus inducing variable stimuli for
renin secretion. The normal pattern of response of
plasma aldosterone to the upright posture in renal
transplant recipients during the third and fourth
postoperative weeks demonstrates that the adrenal
gland regains its capability to respond to the acute
stimulus of elevated plasma renin activity within a
short period after transplantation.
There was no consistent correlation between plasma
renin activity and blood pressure. These findings agree
with those of others [1, 3, 4, 12] although two inves-
tigators have observed a significant correlation
between plasma renin activity and diastolic blood
pressure [5, 29]. From the data presented here it is
concluded that the transient rise in blood pressure
which is frequently observed after renal transplan-
tation is not mainly caused by an activation of the
renin-angiotensin system. In some patients, however,
transient episodes of hypertension, accompanied by
very high plasma renin activities, suggest a causal
relationship [2, 30], but obviously this does not hold
for all patients.
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